Publicaciones en colaboración con investigadores/as de Universidad del País Vasco/Euskal Herriko Unibertsitatea (23)

2023

  1. Melanoma and Nevi Subtype Histopathological Characterization with Optical Coherence Tomography

    Life, Vol. 13, Núm. 3

2020

  1. Serum markers improve current prediction of metastasis development in early-stage melanoma patients: a machine learning-based study

    Molecular Oncology, Vol. 14, Núm. 8, pp. 1705-1718

2019

  1. Imaging Mass Spectrometry–Based Lipidomic Approach to Classification of Architectural Features in Nevi

    Journal of Investigative Dermatology, Vol. 139, Núm. 9, pp. 2055-2058.e7

2018

  1. Metastasis of cutaneous melanoma: risk factors, detection and forecasting

    Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics)

  2. Sleep-Disordered Breathing Is Independently Associated With Increased Aggressiveness of Cutaneous Melanoma: A Multicenter Observational Study in 443 Patients

    Chest, Vol. 154, Núm. 6, pp. 1348-1358

2016

  1. Vitronectin and dermcidin serum levels predict the metastatic progression of AJCC I–II early-stage melanoma

    International Journal of Cancer, Vol. 139, Núm. 7, pp. 1598-1607

2015

  1. Comparison of the transcriptional profiles of melanocytes from dark and light skinned individuals under basal conditions and following ultraviolet-B irradiation

    PLoS ONE, Vol. 10, Núm. 8

2014

  1. Involvement of ANXA5 and ILKAP in susceptibility to malignant melanoma

    PLoS ONE, Vol. 9, Núm. 4

  2. The Interplay between natural selection and susceptibility to melanoma on allele 374F of SLC45A2 gene in a south European population

    PLoS ONE, Vol. 9, Núm. 8

2013

  1. Simultaneous purifying selection on the Ancestral MC1R allele and positive selection on the melanoma-risk Allele V60L in South Europeans

    Molecular Biology and Evolution, Vol. 30, Núm. 12, pp. 2654-2665

2011

  1. A customized pigmentation snp array identifies a novel snp associated with melanoma predisposition in the slc45a2 gene

    PLoS ONE, Vol. 6, Núm. 4

  2. Terfenadine induces apoptosis and autophagy in melanoma cells through ROS-dependent and -independent mechanisms

    Apoptosis, Vol. 16, Núm. 12, pp. 1253-1267

2010

  1. The diversity profile of TP53 is influenced by positive selection on the immediately upstream locus WDR79

    Human Heredity, Vol. 69, Núm. 1, pp. 34-44

2008

  1. Complex signatures of selection for the melanogenic loci TYR, TYRP1 and DCT in humans

    BMC Evolutionary Biology, Vol. 8, Núm. 1

2006

  1. H1 histamine receptor antagonists induce genotoxic and caspase-2-dependent apoptosis in human melanoma cells

    Carcinogenesis, Vol. 27, Núm. 9, pp. 1787-1796

2003

  1. Urticaria recidivante de dos años de evolución

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 21, Núm. 7, pp. 381-382

2000

  1. Interleukin-2 enhances the growth of human melanoma cells derived from primary but not from metastatic tumours

    European Cytokine Network, Vol. 11, Núm. 4, pp. 654-661

  2. Soluble interleukin-2 receptor, intercellular adhesion molecule-1 and interleukin-10 serum levels in patients with melanoma

    British Journal of Cancer, Vol. 83, Núm. 7, pp. 847-852

1997

  1. Serum-soluble IL-2 Receptor and IL-6 levels in patients with melanoma

    Oncology (Switzerland), Vol. 54, Núm. 5, pp. 400-406

1996

  1. Serum interleukin-6 levels in patients with melanoma.

    The International journal of developmental biology, Vol. Suppl 1